Biolight Life Sciences ups number of shares in initial public offerings
Biolight Life Sciences , a global ophthalmology company, said Wednesday that it is raising the number of common shares in its initial public offering to 2.1 million from 1.8 million shares. The company said it is also offering warrants to buy up to 2.1 million shares. The company has applied to list the share on the Nasdaq under the symbol "BOLT." The company's shares are already trading on the Tel Aviv Stock Exchange.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.